Sickle cell paths converge on hydroxyurea.
Platt
O S
OS
Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000209:etiology; D000986:Antisickling Agents / Q000627:therapeutic use*; D001374:Azacitidine / Q000627:therapeutic use; D002648:Child; D005319:Fetal Hemoglobin / Q000502:physiology; D006451:Hemoglobin, Sickle / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D009154:Mutation
D000986:Antisickling Agents; D006451:Hemoglobin, Sickle; D005319:Fetal Hemoglobin; D001374:Azacitidine; D006918:Hydroxyurea